Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $31.5000 (-1.56%) ($31.0600 - $32.5000) on Wed. Nov. 30, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 68 | Latest Price | $31.5000(-1.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 4.6% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IPO(8%) SKYY(8%) PEJ(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.075% in a week (0% probabilities). TLT(-6%) VIXM(-5%) GLD(-5%) GDX(-5%) SLV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $31.72(-0.69%) | 10 Day Moving Average | $31.42(0.25%) | 20 Day Moving Average | $29.94(5.21%) | To recent high | -23% | To recent low | 18.4% | Market Cap | $620m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |